BXN — Bioxyne Cashflow Statement
0.000.00%
Last trade - 00:00- AU$15.21m
- AU$13.47m
- AU$5.16m
Annual cashflow statement for Bioxyne, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | R2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.228 | 0.048 | 0.019 | 0 | -0.216 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1.39 | 0.052 | 0.053 | -0.507 | -1.13 |
| Capital Expenditures | -0.064 | -0.034 | 0 | -0.06 | -0.057 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.109 | 0 | — | 0.087 | 4.02 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Cash from Investing Activities | -0.172 | -0.034 | 0 | 0.027 | 3.96 |
| Financing Cash Flow Items | 0 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0 | -0.052 | -0.047 | 0.493 | 0.947 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.54 | -0.02 | -0.146 | 0.005 | 3.78 |